85 related articles for article (PubMed ID: 28736886)
1. Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area.
Marina M; Ceda GP; Corcione L; Sgargi P; Michiara M; Silini EM; Ceresini G
Head Neck; 2017 Oct; 39(10):2095-2103. PubMed ID: 28736886
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Ceresini G; Corcione L; Michiara M; Sgargi P; Teresi G; Gilli A; Usberti E; Silini E; Ceda GP
Cancer; 2012 Nov; 118(22):5473-80. PubMed ID: 22517468
[TBL] [Abstract][Full Text] [Related]
3. Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.
Bartolone L; Vermiglio F; Finocchiaro MD; Violi MA; French D; Pontecorvi A; Trimarchi F; Benvenga S
J Endocrinol Invest; 1998 Nov; 21(10):680-7. PubMed ID: 9854684
[TBL] [Abstract][Full Text] [Related]
4. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
5. Hurthle cell neoplasms of the thyroid.
Dahl LD; Myssiorek D; Heller KS
Laryngoscope; 2002 Dec; 112(12):2178-80. PubMed ID: 12461336
[TBL] [Abstract][Full Text] [Related]
6. Iodine deficiency a persisting problem: assessment of iodine nutrition and evaluation of thyroid nodular pathology in Portugal.
Santos JE; Freitas M; Fonseca CP; Castilho P; Carreira IM; Rombeau JL; Branco MC
J Endocrinol Invest; 2017 Feb; 40(2):185-191. PubMed ID: 27619914
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period.
Deandrea M; Gallone G; Veglio M; Balsamo A; Grassi A; Sapelli S; Rossi C; Nasi PG; Porcellana V; Varvello G; Capussotti L; Taraglio S; Ravarino N; Torchio B; Fonzo D
J Endocrinol Invest; 1997 Feb; 20(2):52-8. PubMed ID: 9125483
[TBL] [Abstract][Full Text] [Related]
9. Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area.
Huszno B; Szybiński Z; Przybylik-Mazurek E; Stachura J; Trofimiuk M; Buziak-Bereza M; Gołkowski F; Pantoflinski J
J Endocrinol Invest; 2003; 26(2 Suppl):71-6. PubMed ID: 12762644
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
11. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
12. How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?
Pagano L; Mele C; Arpaia D; Samà MT; Caputo M; Ippolito S; Peirce C; Prodam F; Valente G; Ciancia G; Aimaretti G; Biondi B
Endocrine; 2017 Apr; 56(1):129-137. PubMed ID: 27230768
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
[TBL] [Abstract][Full Text] [Related]
14. Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area.
Marina M; Ceda GP; Aldigeri R; Ceresini G
Endocrine; 2017 Aug; 57(2):247-255. PubMed ID: 27738889
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
16. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
17. [Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk].
Szpak S; Zeman M; Handkiewicz-Junak D; Kochańska-Dziurowicz A; Kurzeja E; Stanjek A; Bijak A; Bogacz A; Zemła B
Wiad Lek; 2001; 54 Suppl 1():169-75. PubMed ID: 12182022
[TBL] [Abstract][Full Text] [Related]
18. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
20. Hurthle cell carcinoma in childhood: A retrospective analysis of five cases and review of pediatric literature.
Zirilli G; Valenzise M; Dionigi G; Tuccari G; Romeo C; Campennì A; Corrias A; Tuli G; Ieni A; Pajno GB; Wasniewska M
Pediatr Blood Cancer; 2020 Sep; 67(9):e28300. PubMed ID: 32614144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
